Adaptive Biotechnologies Corp — Director's Dealing 2023

Dec 15, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adaptive Biotechnologies Corp (ADPT)
CIK: 0001478320
Period of Report: 2023-12-13

Reporting Person: NEUPERT PETER M (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-12-13	Common Stock	M	100000	$0.84	Acquired	122968	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-12-13	Stock Option (right to buy)	$.84	M	100000	Disposed	2023-12-23	Common Stock (100000)	Direct

Footnotes

F1: The option vested with respect to 1/4 of the Shares under the grant on the year anniversary of December 23, 2013 and with respect to 1/48 of the Shares under the grant monthly thereafter.